Chronic yersiniasis as a therapeutic problem


Cite item

Full Text

Abstract

Physicians of any specialty encounter the chronic course of yersiniasis, the clinical manifestations of which are polymorphic and similar to the symptoms of other diseases, including autoimmune ones. The long interval of an evolving pathological condition after the acute period of the disease leads to the fact that the clinical and laboratory manifestations of chronic yersiniasis are wrongly regarded as an independent nosological entities unassociated with the persistence of Yersinia. Dynamic blood tests for specific IgA to the Yersinia enterocolitica virulence factors that are an indirect sign of on-going pathogen persistence in the body are required to elaborate the tactics for the examination, treatment, and follow-up of patients.

References

  1. Малов И. В. Роль аутоиммунных процессов при затяжном течении иерсиниоза: Автореф. дис. ... канд. мед. наук. М.; 1998.
  2. Учайкин В. Ф., Гордец А. В., Бениова С. Н. Иерсиниозы у детей. М.: ГЭОТАР-Медиа; 2005.
  3. Labbe L., Perel Y., Maleville J., Taieb A. Erythema nodozum in children: a study of 27 patients. Pediatr. Dermatol. 1996; 13(6): 447-450.
  4. Wildner G., Diedrichs-Mohring M. Autoimmune uveitis induced by molecular mimicry of peptides from rotavirus, bovine casein and retinal S-antigen. Eur. J. Immunol. 2003; 33(9): 2577- 2587.
  5. Zhang H., Kaur I., Niesel D. W. et al. Lipoprotein from Yersinia enterocolitica contains epitopes that cross-react with the Human Thyrotropin Receptor. J. Immunol. 1997; 158: 1976- 1983.
  6. Сидельникова С. М., Ющенко Г. В., Асеева Э. И. Иерсиниозы как терапевтическая проблема. Тер. арх. 2000; 11: 27- 30.
  7. Годзенко А. А. Недифференцированные формы спондилоартритов: проблемы диагностики и классификации. Consilium Medicum 2006; 8(2): 406-411.
  8. Saebo A., Lassen J. Yersinia enterocolitica: an inducer of chronic inflammation. Int. J. Tissue React. 1994; 16(2): 51- 57.
  9. Granfors K., Merilahti-Palo R., Luukkainen R. et al. Persistence of Yersinia antigens in peripheral blood cells from patients with Yersinia enterocolitica O:3 infection with or without reactive arthritis. Arthr. and Rheum. 1998; 41: 855.
  10. O'Connor S. M., Taylor Ch. E., Hughes J. M. Emerging infectious determinants of chronic diseases. Emerg. Infect. Dis. 2006; 12(7): 1051-1057.
  11. Autenrieth I. B., Tingle A., Reske-Kunz A., Heesemann J. T lymphocytes mediate protection against Yersinia enterocolitica in mice: characterization of murine T-cell clones specific for Y. enterocolitica. Infect. and Immun. 1992; 60(3): 1140-1149.
  12. Autenrieth I. B., Beer M., Hantschmann P. et al. The cellular immune response against Yersinia enterocolitica in different inbred strains of mice: evidence for an important role of T lymphocytes. Int. J. Med. Microbiol. Virol. Parasitol. Infect. Dis. 1993; 278(2-3): 383-395.
  13. Autenrieth I. B., Hantschmann P., Heymer B., Heesemann J. Immunohistological characterization of the cellular immune response against Yersinia enterocolitica in mice: evidence for the involvement of T lymphocytes. Immunobiology 1993; 187(1-2): 1-16.
  14. Bohn E., Autenrieth I. B. IL-12 is essential for resistance against Yersinia enterocolitica by triggering IFN-gamma production in NK cells and CD4+ T cell. J. Immunol. 1996; 156(4): 1458-1468.
  15. Kempf V. A. J., Bohn E., Noll A. et al. In vivo tracking and protective properties of Yersinia-specific intestinal T cells. Clin. Exp. Immunol. 1998; 113(3): 429-437.
  16. Di Genaro M. S., Cargnelutti D. E., Castro D. O. et al. Yersinia-triggered arthritis in IL-12p40-deficient mice: relevant antigens and local expression of Toll-like receptor mRNA. Scand. J. Rheumatol. 2007; 36(1): 28-35.
  17. Gutierrez J. G., Valdez S. R., Di Genaro S., Gomez N. N. Interleukin-12p40 contributes to protection against lung injury after oral Yersinia enterocolitica infection. Inflamm. Res. 2008; 57(11): 504-511.
  18. Филатов Н. Н., Салова Н. Я., Голованова В. П., Шестеперова Т. И. Современное состояние лабораторной диагностики иерсиниозов в Москве. В кн.: Инфекции, обусловленные иерсиниями (иерсиниоз, псевдотуберкулез), и другие актуальные инфекции. СПб.; 2000. 59-60.
  19. Опочинский Э. Ф., Мохов Ю. В., Лукина З. А., Ясинский А. А. Анализ деятельности центров ГосСанЭпиднадзора РФ по лабораторной диагностике иерсиниозов. В кн.: Инфекции, обусловленные иерсиниями (иерсиниоз, псевдотуберкулез), и другие актуальные инфекции. СПб.; 2000. 42-43.
  20. Малов И. В., Шурыгина И. А., Волченко Ю. Е. Анализ антител к белкам наружной клеточной мембраны иерсиний при различном течении псевдотуберкулеза у людей. Тер. арх. 1994; 66(4): 62-64.
  21. Физиология человека / Покровский В. М., Коротько Г. Ф., Кобрин В. И. и др. М.: Медицина; 1997; т. 1: 298- 307.
  22. Granfors K., Toivanen A. IgA-anti-yersinia antibodies in yersinia triggered reactive arthritis. Ann. Rheum. Dis. 1986; 45: 561-565.
  23. Heesemann J. Enteropathogenic yersinias: pathogenicity factors and new diagnostic methods (Germany). Immun. and Infect. 1990; 18(6): 186-191.
  24. Hoogkamp-Korstanje J. A. Yersinia infections. Ned. Tijdschr. Geneesk. 1996; 140(3): 128-130.
  25. Stellungnahme des Arbeitskreises Blut: Yersinia enterocolitica. Robert-Koch Institute Berlin. Verabschiedet am 03.05.1999.
  26. Ющук Н. Д., Ценева Г. Я., Кареткина Г. Н., Бродов Л. Е. Иерсиниозы. М.: Медицина; 2003.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies